The Food and Drug Administration stated on Tuesday that it will allow British American Tobacco’s Vuse Solo E-Cigarettes to continue to be sold in the US. Following years of pressure from lawmakers and publichealth groups to regulate the vaping sector as rigorously as other tobacco products, the FDA has decided as part of a broader examination of the industry.The agency’s decision is the first time an E-Cigarettes brand has been approved for sale in the United States. However, some of the flavoured products submitted by R.J. Reynolds Vapor Co. under the Vuse Solo brand were not approved.
In a statement announcing the decision, Mitch Zeller, director of the FDA’s Center for Tobacco Products, said that the manufacturer’s data show its tobacco-flavoured products could benefit addicted adult smokers who switch to these products – either completely or with a significant reduction in cigarette consumption – by reducing their exposure to harmful chemicals. In 2009, the FDA was given the authority to regulate new tobacco products.
E-Cigarettes deliver nicotine to users by vaporizing liquid in cartridges or pods. Nicotine is the ingredient that makes tobacco addictive, and it may have other negative health effects. E-Cigarettes manufacturers have argued that their products can deliver nicotine to addicted adult smokers without the health risks that come along with burning tobacco.
FDA said it was aware that 10% of high school students used E-Cigarettes named Vuse as their usual brand in the 2021 National Youth Tobacco Survey. Over the previous ten years, many cigarette products appeared in the market.